R.W. Pressprich & Co.

Recent Transactions

  • Invisible Sentinel

    $75,000,000 Sale to bioMerieux


    Februrary 2019

  • Bone Biologics

    $6,000,000 Sale of minority interest


    September 2018

  • Fat Brands

    $16,000,000 Senior Term Loan


    July 2018

  • Avation

    $300 mm MTN



    May 2018

  • Hydromx

    Advised In its minority stake sale of SVL


    February 2018

  • Airbus

    $160mm Avolon Structured Note


    December 2017

  • MetLife

    29 ERJ-145s Portfolio Sale


    October 2017

  • BRS

    $600mm MTN



    August 2017

  • AirspeedLimited

    Consent Solicitation



    May 2017

  • LePain

    Advised in minority stake sale


    December 2017

  • Invisible Sentinel

    Aquired by Atlatic Diagnostics Labs



    April 2017

  • Bone Biologics

    $98,000,000 Advised Meridian Labs on Sale of ML-141


    January 2017

  • Pemco

    Debt financing for Energy Efficient Lighting Projects


    November 2016

  • Bridge Equity Funding

    Bridge Equity Funding for Condominium Development in Manhattan

    October 2016

  • ProPhase

    $7,000,000 Purchase of manufacturing assets

    September 2016*

  • Aviation Capital

    $340 mm Equity Advisory and Placement

    January 2017

  • Tanker

    Sale of portfolio of Tanker Vessels


    January 2016

  • Amherst

    Sale of 25% Interest to Magna Pharmaceuticals

    September 2015*

  • Avation

    $100 mm Initial Tranche of $500 mm MTN

    May 2015

  • Oncolix

    $4.2mm Private Placement Financing


    December 2014*

  • BRS

    $110mm Equity and Mezz Financing


    June 2014

  • AspenBioPharma

    acquired by CEVA SA Advisor to AspenBio


    July 2012*

  • chipdx_logo_hr

    acquired by Signal Genetics Advisor to ChipDx

    February 2012*

  • delmarpharma

    Private Placement Financing


    January 2012*

  • Correlogic

    has been acquired by Vermillion, Inc. Advisor to Correlogic

    December 2011*

  • transdel

    Strategic Advisor to Imprimis Advisor to Transdel

    November 2011*

  • MetaMorphix

    Asset sale Advisor to MetaMorphix


    November 2016




*transactions executed while at firms prior to joining RWP